4.855

8.28% 0.385

Ironwood Pharmaceuticals Inc (IRWD)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$4.47

Offen:

$4.68

24-Stunden-Volumen:

798.03K

Relative Volume:

0.34

Marktkapitalisierung:

$799.20M

Einnahmen:

$361.51M

Nettoeinkommen (Verlust:

$102.18M

KGV:

8.1269

EPS:

0.5974

Netto-Cashflow:

$112.21M

1W Leistung:

+17.48%

1M Leistung:

+47.11%

6M Leistung:

+21.61%

1J Leistung:

+541.23%

1-Tages-Spanne:

$4.59

$4.875

1-Wochen-Bereich:

$4.16

$4.875

52-Wochen-Spanne:

$0.6701

$5.78

Ironwood Pharmaceuticals Inc Stock (IRWD) Company Profile

Firmenname

Ironwood Pharmaceuticals Inc

Sektor

Healthcare (1097)

Branche

Drug Manufacturers - Specialty & Generic (86)

Telefon

617-621-7722

Adresse

100 SUMMER STREET, SUITE 2300, BOSTON, MA

Mitarbeiter

100

Twitter

@ironwoodpharma

Nächster Verdiensttermin

2026-08-06

Neueste SEC-Einreichungen

IRWD's Discussions on Twitter

Compare IRWD vs TAK, HLN, TEVA, ZTS, UTHR

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
IRWD Ironwood Pharmaceuticals Inc	4.855	735.82M	361.51M	102.18M	112.21M	0.5974
TAK Takeda Pharmaceutical Co Adr	16.77	53.59B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	9.76	43.33B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	33.54	40.35B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	74.17	31.98B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	559.63	23.93B	3.17B	1.29B	1.01B	27.09

Ironwood Pharmaceuticals Inc Stock (IRWD) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-01-05	Hochstufung	Citizens JMP	Mkt Perform → Mkt Outperform
2025-04-15	Herabstufung	Jefferies	Buy → Hold
2025-04-15	Herabstufung	Wells Fargo	Overweight → Equal Weight
2025-04-14	Herabstufung	Citizens JMP	Mkt Outperform → Mkt Perform
2024-09-09	Eingeleitet	Leerink Partners	Market Perform
2024-08-08	Herabstufung	CapitalOne	Overweight → Equal Weight
2024-01-17	Eingeleitet	Craig Hallum	Buy
2023-12-14	Eingeleitet	Wells Fargo	Overweight
2023-11-09	Eingeleitet	Jefferies	Buy
2023-09-28	Eingeleitet	JMP Securities	Mkt Outperform
2022-09-02	Eingeleitet	CapitalOne	Overweight
2022-04-22	Eingeleitet	Piper Sandler	Overweight
2020-09-30	Herabstufung	Wells Fargo	Overweight → Equal Weight
2020-06-17	Eingeleitet	Northland Capital	Outperform
2019-07-10	Fortgesetzt	Credit Suisse	Neutral
2019-03-27	Hochstufung	Morgan Stanley	Underweight → Equal-Weight
2019-02-25	Hochstufung	H.C. Wainwright	Sell → Neutral
2019-01-24	Hochstufung	JP Morgan	Underweight → Neutral
2018-11-07	Herabstufung	Credit Suisse	Outperform → Neutral
2018-11-07	Herabstufung	JP Morgan	Neutral → Underweight
2018-07-23	Eingeleitet	H.C. Wainwright	Sell
2018-05-09	Herabstufung	Morgan Stanley	Equal-Weight → Underweight
2018-01-05	Herabstufung	BofA/Merrill	Buy → Underperform
2017-12-06	Herabstufung	Mizuho	Buy → Neutral
2017-07-21	Herabstufung	JP Morgan	Overweight → Neutral
2017-05-03	Eingeleitet	Wells Fargo	Outperform
2017-04-07	Bestätigt	Mizuho	Buy
2017-02-22	Bestätigt	Barclays	Equal Weight
2016-11-04	Bestätigt	Mizuho	Buy
2016-10-24	Bestätigt	Wedbush	Neutral
2016-10-10	Bestätigt	Mizuho	Buy
2016-09-27	Bestätigt	WallachBeth	Hold

Alle ansehen

Ironwood Pharmaceuticals Inc Aktie (IRWD) Neueste Nachrichten

Jul 07, 2026

Form 144 IRONWOOD PHARMACEUTICALS For: 7 July By Investing.com - Investing.com Canada

Jul 07, 2026

12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga

Jul 07, 2026

Proposed Common stock sale for IRWD (NASDAQ: IRWD) via Morgan Stanley Smith Barney - Stock Titan

Jul 07, 2026

Jul 04, 2026

Price to earnings forward of Ironwood Pharmaceuticals, Inc. – NASDAQ:IRWD - TradingView

Jul 04, 2026

Jul 03, 2026

Ironwood Pharmaceuticals stock follows its own business case. IRWD trades on Nasdaq. - AD HOC NEWS

Jul 03, 2026

Ironwood Pharmaceuticals (IRWD) Gains From Strong Fiscal Q1 2026 Earnings Momentum - Yahoo Finance

Jul 03, 2026

Jul 02, 2026

Price to book forward of Ironwood Pharmaceuticals, Inc. – NASDAQ:IRWD - TradingView

Jul 02, 2026

Jun 26, 2026

IRWD Forecast — Price Target — Prediction for 2027 - TradingView

Jun 26, 2026

Gastroparesis Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | CinDome Pharma, Inc., Evoke Pharma, Vanda Pharma, Ironwood Pharma, Takeda - Barchart.com

Jun 26, 2026

Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and Marker - The Globe and Mail

Jun 26, 2026

Ironwood Pharmaceuticals, Inc. Class A Actuals & Estimates (BX:I76) - TradingView

Jun 26, 2026

Jun 25, 2026

Ironwood Pharmaceuticals, Inc. Class A Actuals & Estimates (SWB:I76) - TradingView

Jun 25, 2026

Ironwood Pharmaceuticals, Inc. Class A Actuals & Estimates (MUN:I76) - TradingView

Jun 25, 2026

I76 Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

5 Small Drug Stocks to Invest in Amid a Biotech Comeback - Yahoo Finance

Jun 25, 2026

Ironwood Pharmaceuticals (IRWD) Short Interest & Short Float | Updated Jun 2026 - MarketBeat

Jun 25, 2026

Jun 24, 2026